Dupilumab 300mg/2ml solution for injection pre-filled disposable devices
NHS hospitals in England used £191,849,978 of indicative cost of Dupilumab 300mg/2ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.7% of all hospital medicines spend. That is up 28.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Dupilumab 300mg/2ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Dupilumab 300mg/2ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Salford Royal Nhs Foundation Trust | £13,507,128 |
| Guy's & St Thomas' Nhs Foundation Trust | £11,127,237 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £9,615,694 |
| Leeds Teaching Hpls Nhs Trust | £7,176,986 |
| Aintree University Hospital Nhs Ft | £7,099,828 |
| University Hospitals Plymouth Nhs Trust | £6,278,914 |
| Gloucestershire Hpls Nhs Foundation Trst | £5,803,315 |
| Univ Hpls Bristol Nhs Foundation Trust | £5,702,124 |
| Western Sussex Hospitals Nhs Found Trust | £4,893,859 |
| Co.durham & Darlington Nhs Foundation Tr | £3,696,641 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.